Acetylsalicylic acid Not Yet Recruiting Phase 3 Trials for Rheumatic Heart Disease Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02832531INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority